Skip to content
Free previewYou are reading 1 of 31 lessons, in the same interface members use. Everything else unlocks with full access.Get full access · $150

1.1.1 - Decentralized Trial Models and Activities

Decentralized Trial Foundations | Trial Models and Feasibility

Decentralized trial models and activities

A decentralized trial moves selected research activities beyond the principal clinical trial site. A workable model specifies what happens, where it happens, who performs it, and how the investigator and sponsor maintain appropriate control.

What you will learn

  • Differentiate site-based, hybrid, decentralized-element, and fully decentralized models: Decentralized trial foundations, model classification.
  • Identify remote, home-based, local-provider, mobile, and technology-supported activities: Decentralized trial foundations, activity identification.
  • Map each participant-facing activity to its location, performer, records, and oversight route: Decentralized trial foundations, operational mapping.
  • Distinguish moving an activity from transferring a regulatory obligation: Decentralized trial foundations, accountability boundaries.
Estimated time
20-25 minutes.
Blueprint mapping
Decentralized trial foundations → Trial models and activities → bp.d1.t1. Topic weight is not supplied.
Source context
November 1, 2026 course blueprint. The regulatory baseline supplied for this lesson includes the September 2024 FDA final guidance, Conducting Clinical Trials With Decentralized Elements. This lesson uses that supplied baseline; it does not establish whether additional jurisdiction-specific requirements or later changes apply to a particular study.
Prerequisites
Foundational good clinical practice concepts.
Key outputs
You should be able to choose a defensible trial-model description, create an activity-location map, and identify an oversight gap before an activity moves away from the principal site.
WHY

Why it matters

  • A remote visit, wearable device, or home shipment changes how research operates; it does not by itself settle who remains responsible for participant protection or study conduct.
  • Different activities in the same protocol may require different locations. Model selection therefore starts with the activity, rather than a preference to label the whole study remote.
  • The September 2024 FDA final guidance provides the supplied framework for trials with decentralized elements. Its practical use is to design controlled activities, rather than treat decentralization as a separate standard of participant protection.
  • A clear activity map exposes missing safety, record, and communication routes before participants depend on them.
KEY TERMS

Key Terms & Must-Know Facts

Decentralized element
A trial activity conducted beyond the traditional clinical trial site, using an arrangement appropriate to that activity.
Traditional site-based model
A delivery model in which participant trial activities are centered at the research site.
Hybrid model
A study combining site-based activities with activities performed remotely or at other locations.
Fully decentralized model
A study whose participant trial activities occur outside the traditional research site; this description does not remove investigator or sponsor responsibilities.
Principal clinical trial site
The research-site organizational setting around which investigator oversight is arranged, even when some participant activities occur elsewhere.
Telehealth
Remote clinical interaction used for an appropriate protocol activity; it does not supply every capability of an in-person examination.
Electronic informed consent
Use of electronic methods within the consent process and its documentation; a signature alone does not establish participant understanding or voluntariness.
Home nursing
Protocol activities delivered in the participant home by personnel qualified for their assigned tasks.
Local professional certification provider
A professional certification professional near the participant who may perform appropriate trial-related activities under a defined arrangement.
Digital health technology
Technology, such as a wearable device, used to support trial activities or capture data remotely.
Direct-to-participant service
A service delivered directly to a participant, such as an authorized supply shipment, with appropriate handling and oversight arrangements.
Delegation
Assignment of a task to another qualified person or organization within an appropriate responsibility structure.
Transfer of sponsor obligations
A specific regulatory arrangement under which identified sponsor obligations are transferred to a contract research organization in writing.

Must-know facts

  • Decentralized describes activities and their delivery; it is not an automatic transfer of regulatory responsibility.
  • Hybrid and decentralized-element are overlapping descriptions, rather than mutually exclusive regulatory categories.
  • Remote screening, telehealth, electronic consent, home nursing, local laboratories, mobile units, wearables, and direct services are components to evaluate individually.
  • Activity suitability depends on the required procedure, qualified personnel, available capabilities, records, and safety response.
  • For applicable investigational new drug studies, investigator and sponsor requirements continue to apply when activities occur elsewhere.
  • A U.S. regulatory reference does not establish the requirements applicable in Canada or another jurisdiction.
CORE

Core content

1.1.1.1 1. Classify the model by participant activities

A Explanation: choose an activity-based description

WHY THIS IS TESTED: A model label can conceal required site visits or imply that an electronic tool has decentralized the entire study. Choose the description supported by actual participant activities.

Start with the protocol schedule. Identify which activities require attendance at the principal site and which occur at home, through telehealth, at a local facility, or in a mobile unit. A trial with required principal-site visits plus appropriate off-site activities is hybrid. A fully decentralized description requires the participant activity schedule to be delivered outside the traditional research site.

Do not treat these terms as four rigid, exclusive legal classes. A hybrid study has decentralized elements. Conversely, a study can use electronic tools entirely within site visits without moving those activities off site. See Fig 1.

Fig 1. Classify the participant activity schedule
Exam takeaway: Classify the model from required activity locations rather than the technology brand or recruitment message.
flowchart TD; A[Map participant trial activities] --> B{Any activities outside the principal site?}; B -->|No| C[Site-based delivery]; B -->|Yes| D{Required principal-site activities remain?}; D -->|Yes| E[Hybrid delivery with decentralized elements]; D -->|No| F[Fully decentralized participant delivery];
Table 1. Trial-model comparison
Model or descriptorActivity patternInterpretation boundary
Traditional site-basedParticipant activities centered at the principal siteElectronic records alone do not establish off-site delivery.
HybridRequired principal-site activities combined with off-site activitiesSome travel remains even when most contacts are remote.
With decentralized elementsOne or more activities delivered outside the traditional siteDescribes components; does not specify how many site visits remain.
Fully decentralizedParticipant activities delivered outside the traditional research siteDoes not mean absence of an investigator, oversight, or organized records.
One schedule, three delivery patterns
Exam takeaway: Compare the locations of the same protocol activities when distinguishing delivery models.
{"prompt":"Create a clean educational three-panel illustration on white with blue-gray outlines and teal accents. Left panel: participant travels to a research site for screening, consent, assessment, and samples. Center panel: participant attends the research site for a required procedure but completes telehealth follow-up and a home sample visit. Right panel: participant completes appropriate trial activities at home and a local laboratory with no principal-site attendance. Include a separate investigator oversight symbol connected to all three panels. Label panels Site-based, Hybrid, and Fully decentralized. Do not suggest that any model is universally preferable. Keep all labels inside generous margins.","caption":"One schedule, three delivery patterns","size":"1024x1024"}
Fig 2. Tool adoption versus activity relocation
Exam takeaway: A digital tool changes the model only when its use changes where a participant activity occurs.
flowchart TD; A[Electronic consent platform] --> B{Where does consent occur?}; B --> C[At the principal site]; B --> D[Remotely with an appropriate consent process]; C --> E[Digital tool within site-based activity]; D --> F[Decentralized consent activity];

Use the location test in Fig 2 when a study is described as digital. Electronic capture and decentralized delivery answer different questions.

Model classification workflow
Exam takeaway: Confirm the required participant itinerary before choosing the model label.
1. List required participant activities.
2. Identify principal-site attendance.
3. Identify off-site delivery.
4. Select the supported description.

B Worked example: required visits outweigh a remote label

A 67-year-old participant with hypertension and osteoarthritis is considering a study advertised as virtual. A screening report also notes a mildly elevated cholesterol result. The protocol requires a principal-site baseline procedure and final assessment; interim contacts use telehealth and a wearable. The coordinator points out that nearly all weekly contacts occur at home.

  1. Identify the task: Classify delivery, rather than decide eligibility or interpret cholesterol.
  2. Extract key facts: Required principal-site activities remain, and interim activities occur remotely.
  3. Apply the rule: The combined schedule supports a hybrid description.
  4. Eliminate alternatives: The number of remote contacts and the virtual advertisement do not erase mandatory site attendance.
  5. Verify: Check the full schedule for additional visits and explain travel requirements accurately to the participant.

C Exam trap: counting contacts instead of locations

Common wrong answer: Fully decentralized because most contacts are remote. Why tempting: The numerical majority seems to define the model. Single eliminating clue: A principal-site procedure is still mandatory.

D Checkpoint MCQ

A study uses electronic consent at the research site, where every scheduled participant assessment also occurs. Which description is best supported?

  1. A. Site-based delivery using electronic tools.
  2. B. Hybrid delivery because consent is electronic.
  3. C. Fully decentralized delivery because records are digital.
  4. D. Decentralized consent delivery because the signature is electronic.

Answer: A. A is attractive and correct because the participant activity locations remain at the site. B is tempting because electronic consent often supports remote participation, but no off-site activity is described. C is tempting because digital records reduce physical paperwork, but records do not determine participant location. D is tempting because a signature is captured electronically, but the consent activity itself remains at the research site.

If you missed this: Review Classify the model by participant activities - focus on activity location rather than electronic format.

1.1.1.2 2. Match each activity to a capable setting

A Explanation: choose capability over convenience

WHY THIS IS TESTED: An activity can be convenient to move but unsuitable for a proposed setting. Choose a location that can perform the actual protocol task and support an appropriate response when something goes wrong.

Decompose broad labels. Screening may include remote discussion, document review, measurements, and procedures that have different location needs. A telehealth contact does not automatically replace a required examination. A local laboratory may collect a specimen but still need instructions for identification, handling, and returning results. Home nursing and local providers require task-appropriate qualifications and an agreed communication route.

Electronic consent must support a legally effective process, including understandable information, voluntary participation, adequate opportunity for consideration, and required consent information. Direct-to-participant supply requires a separate suitability and control assessment; delivery convenience alone cannot authorize product use. These components are introduced here and developed in later course topics.

Table 2. Activity-to-setting reference map
ComponentPossible setting or methodOperational question before assignment
Remote screeningTelephone, telehealth, secure document exchangeWhich screening elements can be completed this way, and which need another setting?
Electronic consentRemote platform-supported discussion and documentationHow can the participant consider information, ask questions, and document consent appropriately?
Telehealth assessmentParticipant home or another suitable remote locationCan the required assessment be completed reliably without physical attendance?
Home nursingParticipant homeAre personnel qualified and equipped for the assigned task and escalation needs?
Local laboratoryLocal collection or testing facilityHow will participant identity, specimen handling, results, and urgent findings be managed?
Mobile research unitProtocol-appropriate mobile facilityDoes the unit provide the required capabilities, records, and safety arrangements?
Local professional certification providerLocal practice or other appropriate care settingWhat task is assigned, and how will trial-relevant information reach the investigator?
Wearable deviceParticipant daily environment with remote data transferIs the device suitable for the intended measure, and how are missing data or relevant alerts handled?
Direct-to-participant serviceAuthorized delivery to an appropriate participant locationAre recipient authorization, handling, storage, accountability, and support addressed?
Fig 3. Choose a setting for a specific activity
Exam takeaway: Keep or redesign an activity when the proposed off-site setting cannot meet its requirements.
flowchart TD; A[Define the protocol task] --> B{Can the proposed setting meet task requirements?}; B -->|No| C[Retain a capable setting or redesign appropriately]; B -->|Yes| D{Are personnel records and escalation arranged?}; D -->|No| E[Resolve the operating gaps]; D -->|Yes| F[Assign the activity with documented arrangements];

Apply the setting decision in Fig 3 separately to each procedure. A suitable location for an interview may be unsuitable for a procedure requiring capabilities unavailable there.

Telehealth capability comparison
Exam takeaway: A remote conversation and an instrument-dependent examination have different setting requirements.
{"prompt":"Educational side-by-side operational comparison on a white background with blue-gray lines and teal accents. Left: a participant at home in a private video discussion with a research clinician, labeled Protocol interview. Right: a participant at a qualified facility with a clinician and examination equipment, labeled Required instrument-based assessment. Between panels place a decision card reading Match the setting to the task. Avoid disease-specific treatment, product branding, and any implication that a video call supplies physical examination equipment.","caption":"Telehealth capability comparison","size":"1024x1024"}
Home visit and local laboratory handoffs
Exam takeaway: Local delivery requires planned identity, specimen, result, and safety communication routes.
{"prompt":"Clean semi-flat educational illustration of two connected trial service locations. At left a qualified home nurse confirms participant identity before a protocol sample collection at a home table. At right a local laboratory receives an identified specimen and returns results to an investigator record system. Add four simple labeled cards: Identity, Handling, Results, Urgent finding route. Show secure communication arrows and no participant identifiers or numerical laboratory values. White background, thin blue-gray outlines, teal accents, all text inside clear margins.","caption":"Home visit and local laboratory handoffs","size":"1024x1024"}
Setting suitability workflow
Exam takeaway: Approve a setting only after its capabilities and response arrangements match the assigned activity.
1. Specify the activity requirements.
2. Check location capabilities.
3. Confirm qualified personnel.
4. Establish records and escalation.
5. Retain, relocate, or redesign.

B Worked example: a convenient visit lacks required capabilities

A 59-year-old participant with diabetes and chronic back pain prefers home visits. A recent report lists a stable mildly elevated glucose result. The protocol includes an interview and an examination requiring equipment unavailable to the visiting nurse. The vendor states that its staff already support several remote trials.

  1. Identify the task: Assign appropriate locations for two different activities.
  2. Extract key facts: The interview may be feasible remotely, but the examination requires unavailable equipment.
  3. Apply the rule: Match each activity to actual capabilities; experience with other trials is not a substitute.
  4. Eliminate alternatives: Neither the participant preference nor the stable glucose result authorizes omission or substitution of the required examination.
  5. Verify: Keep the examination at a capable setting or pursue an appropriately authorized redesign; confirm the interview arrangement separately.

C Exam trap: assuming one remote method fits a whole visit

Common wrong answer: Move every procedure in the visit to telehealth. Why tempting: The appointment has one calendar entry and a remote-ready vendor. Single eliminating clue: One procedure needs capabilities absent from the remote setting.

D Checkpoint MCQ

A local laboratory is proposed for protocol sample collection. Which initial assessment best supports the assignment?

  1. A. Whether its location and hours are preferred by most participants.
  2. B. Whether it can meet collection, handling, result-routing, and escalation needs.
  3. C. Whether its routine reports resemble the research-site report format.
  4. D. Whether the same vendor has served other decentralized studies.

Answer: B. A is tempting because access affects participation, but convenience does not establish task capability. B is correct because it addresses the activity and its critical handoffs. C is tempting because familiar formatting may ease review, but appearance does not establish reliable collection or communication. D is tempting because prior experience suggests readiness, but this protocol requires its own capability assessment.

If you missed this: Review Match each activity to a capable setting - focus on protocol-specific capabilities before convenience or vendor history.
Quick Recall:
  • A trial with required principal-site visits and home follow-up is what model? Hybrid.
  • True or false: an electronic signature proves an activity occurred remotely. False.
  • A local service is suitable only if it can meet the assigned ______. Activity requirements.

1.1.1.3 3. Separate task location from regulatory accountability

A Explanation: choose the documented responsibility structure

WHY THIS IS TESTED: A vendor can perform an activity without assuming every related sponsor or investigator obligation. Choose the responsibility allocation supported by the applicable regulatory framework and documentation.

For applicable U.S. investigational new drug investigations, the supplied blueprint identifies sponsor duties concerning investigator selection, information provision, monitoring, protocol compliance, and safety communication. Investigator duties include appropriate study conduct, participant protection, investigational drug control, safety reporting, and records. Moving a contact to a home nurse or a technology provider does not by itself relocate those duties.

A contract research organization may assume identified sponsor obligations through the written transfer described in 21 CFR 312.52. Distinguish those transferred obligations from untransferred duties and broader sponsor oversight responsibilities. Do not teach either extreme: that outsourcing transfers everything, or that a properly documented regulatory transfer has no effect. See Fig 4.

Fig 4. Task assignment and obligation transfer are different decisions
Exam takeaway: Determine what was assigned and what was formally transferred before allocating regulatory responsibility.
flowchart TD; A[Off-site provider performs a task] --> B[Identify task assignment and oversight]; A --> C{Written transfer of sponsor obligations to a CRO?}; C -->|Yes| D[Identify specific transferred obligations]; C -->|No| E[Do not infer regulatory transfer]; D --> F[Map transferred and untransferred responsibilities]; E --> F;
Table 3. Similar arrangements with different implications
ArrangementWhat it establishesWhat must still be determined
Home nurse assigned a protocol taskAn identified performer for the activityQualifications, investigator oversight, records, and safety communication
Vendor contract for a platformA defined technology serviceData responsibilities, review routes, continuity, and whether any other documented allocation applies
Written CRO obligation transfer under applicable U.S. rulesRegulatory responsibility for the identified transferred obligationsExact transfer scope, untransferred duties, and broader sponsor oversight
Participant performs a home activityA protocol-supported participant actionTraining, support, records, appropriate control, and escalation
Local provider delivers routine careA professional certification interactionWhether a research task is assigned and how relevant trial information reaches the investigator
Distributed performance with defined oversight
Exam takeaway: Show who performs each task without implying that every performer assumes all regulatory duties.
{"prompt":"Create a precise educational responsibility illustration with a participant home, local laboratory, and digital platform linked to an investigator oversight desk. Place a sponsor and CRO agreement folder above with two labeled tabs: Transferred obligations and Untransferred duties. Use distinct arrows labeled Task performance, Information, and Oversight. Do not draw an arrow suggesting that all accountability leaves the sponsor or investigator. White background, blue-gray outlines, teal accent, readable concise labels, no legal seals or agency endorsements.","caption":"Distributed performance with defined oversight","size":"1024x1024"}
Responsibility allocation workflow
Exam takeaway: Service delivery and regulatory responsibility need separate documentation checks.
1. Identify the applicable framework.
2. Identify the task performer.
3. Check documented transfer scope.
4. Map remaining duties and oversight.

B Worked example: a service agreement does not answer every question

A 72-year-old participant with chronic kidney disease and hypertension reports dizziness during a home visit. A routine chemistry report also contains a borderline sodium result. The home nursing contract includes visit documentation and transmission to the site. A coordinator argues that the nursing company should handle the entire research safety-reporting process because its nurse first heard the complaint.

  1. Identify the task: Determine the information route and responsibility structure, without diagnosing the symptom.
  2. Extract key facts: The provider performs home visits and sends records; no transfer of all safety obligations is established.
  3. Apply the rule: Route relevant safety information through the defined investigator and sponsor arrangements, with immediate clinical response as appropriate to the situation.
  4. Eliminate alternatives: First receipt of a complaint does not establish ownership of every regulatory assessment or submission.
  5. Verify: Confirm receipt, qualified review, and applicable escalation; separately inspect any written CRO transfer if responsibility remains disputed.

C Exam trap: assigning responsibility to the first observer

Common wrong answer: The home provider automatically assumes all sponsor safety obligations. Why tempting: It is closest to the event and has a service contract. Single eliminating clue: The stated assignment covers visits and transmission, not a specified transfer of sponsor obligations.

D Checkpoint MCQ

A CRO is performing decentralized trial services. Which evidence is most directly relevant to determining whether specific sponsor obligations were transferred under the supplied U.S. framework?

  1. A. A participant brochure identifying the CRO support telephone number.
  2. B. A vendor presentation describing full-service trial capability.
  3. C. A written statement identifying the sponsor obligations transferred.
  4. D. A schedule showing that the CRO conducts most participant contacts.

Answer: C. A is tempting because it identifies an operational contact, but it does not define regulatory transfer. B is tempting because broad capability sounds comprehensive, but a service claim is not a specified transfer. C is correct because the identified written scope addresses the transfer question directly. D is tempting because the CRO performs substantial work, but activity volume does not establish which obligations were transferred.

If you missed this: Review Separate task location from regulatory accountability - focus on the specific written transfer scope.

1.1.1.4 4. Build an activity map that can be operated

A Explanation: choose a complete handoff over a list of locations

WHY THIS IS TESTED: A list of homes, clinics, and devices can appear complete while leaving results unread or safety concerns unreported. Choose a map that connects performance to records, review, escalation, and a fallback.

For every participant-facing activity, record its purpose, location, performer, qualifications needed, source record, destination, responsible reviewer, and response route. Identify a workable alternative for failed connectivity, a missed home visit, an unavailable local service, or an unsuitable shipment destination. The fallback must preserve the protocol and applicable approvals; operational inconvenience does not authorize an improvised substitution.

A technology-supported environment is a delivery and information setting, not an independent accountable clinician. Device data need a defined route to the study team. Do not imply that a wearable dashboard is an emergency service or that every transmitted measure is watched continuously unless that service is actually specified.

See Fig 5 for the connected map and Fig 6 for a launch decision. Detailed feasibility and participant burden are developed in the next topic, Feasibility and Participant-Centered Design.

Fig 5. Connect the activity to review and response
Exam takeaway: An activity map is incomplete until the information has an identified destination and reviewer.
flowchart TD; A[Participant-facing activity] --> B[Location and qualified performer]; B --> C[Identified source record]; C --> D[Defined transfer destination]; D --> E[Assigned review and escalation]; E --> F[Documented follow-through and fallback];
Wearable data require an operational route
Exam takeaway: A device-to-dashboard connection does not establish who reviews data or responds to concerns.
{"prompt":"Educational illustration of a participant wearing a research wrist sensor at home. Show a secure transfer arrow to a study dashboard, then an arrow to an assigned study reviewer and a separate participant support contact card. Include a visible unanswered planning card labeled Review schedule and escalation must be defined. Show a disconnected signal symbol with a fallback contact route. Avoid numerical vital signs, automated diagnosis, treatment recommendations, or any suggestion of continuous emergency monitoring. White background, blue-gray outlines, teal accent.","caption":"Wearable data require an operational route","size":"1024x1024"}
Fig 6. Decide whether an activity is ready to move
Exam takeaway: Resolve missing capability, responsibility, record, or response arrangements before off-site activation.
flowchart TD; A[Proposed off-site activity] --> B{Capability and qualifications confirmed?}; B -->|No| C[Resolve gap before activation]; B -->|Yes| D{Records review and safety route defined?}; D -->|No| C; D -->|Yes| E{Protocol alignment and fallback confirmed?}; E -->|No| C; E -->|Yes| F[Activate within documented arrangements];
Participant itinerary with a controlled fallback
Exam takeaway: A practical model includes an agreed alternative when a planned decentralized service fails.
{"prompt":"Create a clean participant itinerary illustration with four cards: research-site procedure, home telehealth contact, local laboratory visit, and authorized supply delivery. Beneath the home telehealth card show a connectivity failure symbol leading to a study-team contact card and then a card labeled Approved alternative. Show the investigator reviewing the itinerary. Do not depict automatic dose changes, unauthorized shipment release, or unsupervised protocol substitution. White background, thin blue-gray lines, teal highlights, generous margins and short readable labels.","caption":"Participant itinerary with a controlled fallback","size":"1024x1024"}
Activity-map completion workflow
Exam takeaway: The map must support execution and recovery, not merely describe intended locations.
1. Name the activity and setting.
2. Assign qualified performance.
3. Connect records to review.
4. Define safety communication.
5. Confirm the permitted fallback.

B Worked example: a dashboard with no reviewer

A 64-year-old participant with asthma and osteoarthritis uses a study wearable at home. A screening report also notes a stable low-normal hemoglobin result. The technology vendor demonstrates successful upload and an attractive dashboard. The operating plan does not identify who reviews incoming records or what happens when the device disconnects.

  1. Identify the task: Decide whether the remote activity is operationally ready.
  2. Extract key facts: Upload works, but review ownership and the outage response are missing.
  3. Apply the rule: Complete the information, review, and fallback routes before activation.
  4. Eliminate alternatives: Dashboard appearance and the unrelated screening result do not establish a complete operating pathway.
  5. Verify: Confirm assigned review, expected communication, participant support instructions, and the protocol-consistent response to missing data.

C Exam trap: equating transmission with oversight

Common wrong answer: Activate because all test files reached the platform. Why tempting: Successful upload looks like end-to-end readiness. Single eliminating clue: No responsible reviewer is assigned.

D Checkpoint MCQ

Which activity-map entry most clearly identifies an actionable handoff?

  1. A. Home sample collection; approved courier; delivery tracking available.
  2. B. Local testing; electronic results; familiar report layout.
  3. C. Telehealth follow-up; qualified clinician; participant satisfaction survey.
  4. D. Local testing; named result destination and reviewer; defined urgent finding route.

Answer: D. A is tempting because transport is organized, but it does not identify result review. B is tempting because results are electronic, but electronic availability does not assign action. C is tempting because clinical qualification matters, but satisfaction measurement does not define the information handoff. D is correct because it connects the output to an identified review and response pathway, although other activity requirements still need confirmation.

If you missed this: Review Build an activity map that can be operated - focus on named review and response routes.
Quick Recall:
  • Does a service contract alone establish transfer of all sponsor obligations? No; inspect the identified transfer scope.
  • Complete the chain: activity → source record → destination → ______. Assigned review and escalation.
  • True or false: failed connectivity permits any convenient substitute procedure. False; the fallback must preserve protocol and applicable approval requirements.
TRAPS

Exam Traps & Differentiators

Common traps & distractors: The most common reasoning error is accepting a broad label as proof that its operating details are settled. A statement such as fully supported is tempting because it sounds comprehensive; the eliminating clue is an unanswered task-specific requirement.

  • Local care equals research assignment: Tempting because the same clinician may provide both; the eliminating clue is that no protocol task has been assigned.
  • Mobile unit equals principal-site attendance: Tempting because both have staff and equipment; the eliminating clue is the actual location and organization of the participant activity.
  • Remote consent equals completed consent: Tempting because a signed record exists; the eliminating clue is that the process has not established the required opportunity for consideration and questions.
  • U.S. framework equals universal permission: Tempting because it offers a familiar rule set; the eliminating clue is a study location under another jurisdiction.

Looks similar but is not: Use Table 3 to distinguish an assigned service, a technology contract, and a specified transfer of sponsor obligations. Similar contracting language can produce different responsibility questions.

  • If the scenario says required research-site procedure, think participant itinerary before model label.
  • If the scenario says equipment unavailable, think task capability before location preference.
  • If the scenario says CRO assumes obligations, think identified written scope.
  • If the scenario says records uploaded, think review ownership and response.
Review connection: Return to Build an activity map that can be operated and check whether the proposed model connects every activity to a usable review and escalation route.
What is coming next: This source pack does not identify a proposed rule, scheduled regulatory change, or adoption statistic. For a real study, confirm the requirements currently applicable to its jurisdictions and activities. Later lessons examine technology validation, electronic consent, investigational product supply, and Canadian operations in greater detail.
ALGO

Algorithm / Approach

Use this five-step approach when choosing or reviewing a delivery model. The output is a supported model description plus a list of resolved and unresolved operating requirements.

1. Inventory: List protocol-required participant activities and applicable geography.
2. Place: Match each activity to a capable location and qualified performer.
3. Allocate: Distinguish performance assignments, investigator oversight, and specified sponsor-obligation transfers.
4. Connect: Define records, review, safety communication, participant support, and protocol-consistent fallback.
5. Verify: Resolve gaps before activation and describe the model from the resulting participant itinerary.
QUIZ

Self-check quiz

Select the single best answer for each question.

1. A protocol requires principal-site baseline imaging, local laboratory collection, and telehealth follow-up. Which description is most informative?

  1. A. Fully decentralized because follow-up is remote.
  2. B. Hybrid with decentralized laboratory and follow-up activities.
  3. C. Site-based because baseline imaging occurs at the research site.
  4. D. Fully decentralized because the laboratory is not the principal site.

2. A sponsor proposes moving a required assessment to a participant home. What is the most appropriate first operational question?

  1. A. Can the proposed home arrangement meet the actual assessment requirements?
  2. B. Can the vendor offer the visit at a lower service price?
  3. C. Can participant preference be recorded in the scheduling system?
  4. D. Can the assessment be entered through the existing data portal?

3. A CRO performs remote visits and has accepted specified sponsor obligations in writing. How should responsibilities be evaluated?

  1. A. Treat all sponsor obligations as transferred because visits are outsourced.
  2. B. Treat the written transfer as a service description with no regulatory effect.
  3. C. Allocate obligations according to which organization first receives participant data.
  4. D. Review the identified transfer scope, untransferred duties, and broader sponsor oversight.

4. A wearable platform passes transmission testing, but incoming data have no assigned reviewer. Which action best addresses the readiness gap?

  1. A. Expand transmission testing until more files reach the platform.
  2. B. Add the wearable vendor contact number to the recruitment brochure.
  3. C. Define review ownership, communication arrangements, and the relevant fallback before activation.
  4. D. Ask participants to check their own dashboard instead of assigning study review.

5. A hybrid protocol includes a remote interview and a procedure requiring equipment unavailable at home. The participant strongly prefers no travel. Which plan is best supported?

  1. A. Use telehealth for both activities because preference favors remote delivery.
  2. B. Assess the interview for remote delivery and retain a capable setting for the procedure unless an appropriate redesign is authorized.
  3. C. Use the home nurse for the procedure because professional qualification replaces the equipment requirement.
  4. D. Delay the equipment-dependent procedure indefinitely while continuing all other visits.
ANSWERS

Answer key & explanations

1. Answer: B

A: Tempting because follow-up is remote; incorrect because mandatory principal-site imaging remains. B: Correct because it identifies both the mixed itinerary and the actual decentralized components. C: Tempting because a major procedure is site-based; incorrect because local collection and remote follow-up are also part of the model. D: Tempting because a local laboratory is off site; incorrect because one off-site component does not eliminate required principal-site attendance.

If you missed this: Review Classify the model by participant activities - focus on the complete required itinerary.

2. Answer: A

A: Correct because activity capability determines whether the location is suitable. B: Tempting because cost matters operationally; incorrect as the first decision because affordability cannot establish assessment suitability. C: Tempting because participant-centered planning matters; incorrect as the first question because recording preference does not establish that the activity can be performed there. D: Tempting because data entry is necessary; incorrect because entering an assessment is different from performing it appropriately.

If you missed this: Review Match each activity to a capable setting - focus on defining the required task before selecting its location.

3. Answer: D

A: Tempting because the CRO performs a visible part of the trial; incorrect because performance does not expand a specified transfer to every obligation. B: Tempting because the sponsor retains important responsibilities; incorrect because a qualifying written transfer has regulatory significance for identified obligations. C: Tempting because data receipt is observable; incorrect because responsibility is not allocated simply by first receipt. D: Correct because it distinguishes transferred obligations from the remaining responsibility and oversight structure.

If you missed this: Review Separate task location from regulatory accountability - focus on the legal significance and limits of the specified transfer.

4. Answer: C

A: Tempting because technical reliability is measurable; incorrect because more successful uploads do not assign a reviewer. B: Tempting because a contact number appears to provide support; incorrect because it does not establish the study review and response pathway. C: Correct because it closes the operational gap between received data and accountable follow-through. D: Tempting because participants can access their own information; incorrect because participant access does not replace the defined study oversight arrangement.

If you missed this: Review Build an activity map that can be operated - focus on connecting data arrival to assigned review.

5. Answer: B

A: Tempting because avoiding travel reduces burden; incorrect because preference cannot supply missing procedural capabilities. B: Correct because it separates activities and preserves the equipment-dependent requirement while allowing an appropriate redesign pathway. C: Tempting because a qualified nurse can perform many home activities; incorrect because qualification does not replace necessary equipment. D: Tempting because it avoids immediate travel or redesign; incorrect because indefinite deferral is not established as protocol-consistent.

If you missed this: Review Match each activity to a capable setting - focus on separate suitability decisions for separate procedures.
RAPID

Rapid review / cheat-sheet

  • Ambiguous model label → reconstruct the participant itinerary.
  • Single calendar visit → separate its procedures before assigning locations.
  • Local provider involvement → distinguish routine care from an assigned research task.
  • Electronic consent record → assess the consent process as well as its documentation.
  • Wearable dashboard → identify the service actually promised to the participant.
  • Delivery to a home → verify the authorized supply and handling arrangement.
  • Service outage → use a protocol-consistent recovery pathway.
  • Cross-border execution → confirm geographic applicability before importing an operating rule.

Key points

  • Describe the delivery model from actual participant activities.
  • Match each activity to qualified personnel and a capable setting.
  • Document task performance separately from regulatory responsibility allocation.
  • Connect remote execution to records, review, safety communication, and recovery.

Blueprint anchor recap: Decentralized trial foundations → Trial models and activities, bp.d1.t1. This lesson addresses model differentiation, component recognition, participant activity mapping, and the distinction between decentralized performance and regulatory accountability. It introduces later topics without substituting for their detailed requirements.

References / further study

U.S. Food and Drug Administration. Conducting Clinical Trials With Decentralized Elements: Guidance for Industry, Investigators, and Other Interested Parties. Sept. 2024. Guidance identified in the supplied course blueprint.

United States. Code of Federal Regulations. Title 21, sections 312.50, 312.52, 312.53, 312.56, 312.60-312.64, and 312.32. Regulatory anchors identified in the supplied course blueprint.

United States. Code of Federal Regulations. Title 21, sections 50.20 and 50.25. Informed-consent anchors identified in the supplied course blueprint.

End of your free lesson

Keep going with the full Decentralized and Hybrid Clinical Trials Certificate Program

You just studied the way members do, in the same lesson interface. Full access unlocks every lesson, the question bank and flashcards for a full year.

Up next with full access1.1.2 - Feasibility and Participant-Centered Design

One payment per program